← Back to Screener
Ekso Bionics Holdings, Inc. Common Stock (EKSO)
Price$10.40
Favorite Metrics
Price vs S&P 500 (26W)91.82%
Price vs S&P 500 (4W)-9.84%
Market Capitalization$37.06M
All Metrics
Book Value / Share (Quarterly)$2.54
P/TBV (Annual)5.30x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-0.29%
Cash Flow / Share (Quarterly)$-3.37
Price vs S&P 500 (YTD)16.11%
Gross Margin (TTM)53.48%
Net Profit Margin (TTM)-91.37%
EPS (TTM)$-4.95
10-Day Avg Trading Volume0.09M
EPS Excl Extra (TTM)$-4.95
Revenue Growth (5Y)7.59%
EPS (Annual)$-4.82
ROI (Annual)-89.39%
Gross Margin (Annual)53.48%
Net Profit Margin (5Y Avg)-88.26%
Cash / Share (Quarterly)$0.33
Revenue Growth QoQ (YoY)-38.31%
ROA (Last FY)-58.15%
Revenue Growth TTM (YoY)-28.60%
EBITD / Share (TTM)$-4.86
ROE (5Y Avg)-84.96%
Operating Margin (TTM)-104.12%
Cash Flow / Share (Annual)$-3.37
P/B Ratio4.11x
P/B Ratio (Quarterly)3.25x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)3.12x
Net Interest Coverage (TTM)-8.18x
ROA (TTM)-50.71%
EV / EBITDA (TTM)0.89x
EPS Incl Extra (Annual)$-4.82
Current Ratio (Annual)1.63x
Quick Ratio (Quarterly)0.98x
3-Month Avg Trading Volume1.52M
52-Week Price Return80.95%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.55
P/S Ratio (Annual)2.90x
Asset Turnover (Annual)0.64x
52-Week High$13.50
Operating Margin (5Y Avg)-95.89%
EPS Excl Extra (Annual)$-4.82
CapEx CAGR (5Y)-9.22%
Tangible BV CAGR (5Y)0.06%
26-Week Price Return95.80%
Quick Ratio (Annual)0.98x
13-Week Price Return16.86%
Total Debt / Equity (Annual)0.45x
Current Ratio (Quarterly)1.63x
Enterprise Value$39.946
Revenue / Share Growth (5Y)33.59%
Asset Turnover (TTM)0.56x
Book Value / Share Growth (5Y)36.68%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.27x
Pretax Margin (Annual)-91.37%
Cash / Share (Annual)$0.33
3-Month Return Std Dev94.88%
Gross Margin (5Y Avg)52.86%
Net Income / Employee (TTM)$-0
ROE (Last FY)-129.56%
Net Interest Coverage (Annual)-34.23x
EPS Basic Excl Extra (Annual)$-4.82
Receivables Turnover (TTM)1.76x
Total Debt / Equity (Quarterly)0.45x
EPS Incl Extra (TTM)$-4.95
Receivables Turnover (Annual)1.76x
ROI (TTM)-77.87%
P/S Ratio (TTM)2.90x
Pretax Margin (5Y Avg)-88.26%
Revenue / Share (Annual)$5.28
Tangible BV / Share (Annual)$1.55
Price vs S&P 500 (52W)51.12%
Year-to-Date Return18.75%
5-Day Price Return27.93%
EPS Normalized (Annual)$-4.82
ROA (5Y Avg)-41.99%
Net Profit Margin (Annual)-91.37%
Month-to-Date Return-3.66%
Cash Flow / Share (TTM)$-1.03
EBITD / Share (Annual)$-4.85
Operating Margin (Annual)-104.12%
LT Debt / Equity (Annual)0.09x
ROI (5Y Avg)-61.41%
LT Debt / Equity (Quarterly)0.09x
EPS Basic Excl Extra (TTM)$-4.95
P/TBV (Quarterly)5.30x
P/B Ratio (Annual)3.25x
Inventory Turnover (TTM)1.27x
Pretax Margin (TTM)-91.37%
Book Value / Share (Annual)$2.54
Price vs S&P 500 (13W)16.17%
Beta0.75x
Revenue / Share (TTM)$3.99
ROE (TTM)-110.52%
52-Week Low$2.73
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.00
Industry Peers — General Industrial Machinery(12)
| Symbol | P/E Ratio (Annual) | Revenue Growth (5Y) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
EKSOEkso Bionics Holdings, Inc. Common Stock | — | 7.59% | -104.12% | -110.52% | $10.40 |
SYMSymbotic Inc. Class A Common Stock | — | 89.44% | -3.51% | -3.34% | $60.56 |
NDSNNordson Corp | 31.30x | 5.65% | 25.90% | 17.30% | $276.70 |
RRXRegal Rexnord Corporation | 47.30x | 15.34% | 11.47% | 4.19% | $196.07 |
ESABESAB Corporation | 27.23x | 7.83% | 14.50% | 10.98% | $98.93 |
ATSATS Corporation | — | 12.12% | 2.75% | 1.08% | $31.30 |
OUSTOuster, Inc. | — | 55.05% | -43.69% | -26.89% | $24.17 |
SERVServe Robotics Inc. Common Stock | — | — | -4421.62% | -38.54% | $9.45 |
RRRichtech Robotics Inc. Class B Common Stock | — | — | -523.91% | -10.68% | $2.39 |
AZA2Z Cust2Mate Solutions Corp. Common Shares | — | 40.56% | -350.58% | -85.48% | $8.39 |
TAYDTaylor Devices Inc | 18.64x | 10.28% | 21.86% | 15.76% | $54.15 |
About
Ekso Bionics designs and manufactures wearable exoskeletons that augment human strength, endurance, and mobility in healthcare and industrial applications. The company operates two business segments—Enterprise Health and Personal Health—serving customers across the Americas, EMEA, and APAC regions. All operations are based in the United States.